A PET study evaluating dopamine D2 receptor occupancy for long-acting injectable risperidone

The American Journal of Psychiatry
G RemingtonS Kapur

Abstract

Long-acting injectable risperidone represents the first clinically available depot atypical antipsychotic. The present study used positron emission tomography (PET) to evaluate its dopamine D(2) binding profile at doses of 25, 50, or 75 mg administered every 2 weeks. After achieving stabilization with one of the doses, nine patients with a diagnosis of schizophrenia or schizoaffective disorder underwent [(11)C]raclopride PET to measure D(2) occupancy. Participants were scanned twice during the 2-week injection interval: within 3 days after injection (postinjection) and within 5 days before the next injection (preinjection). At the same time, plasma was collected for measurements of risperidone plus 9-hydroxyrisperidone. Mean post- and preinjection D(2) occupancy levels for the 25-, 50-, and 75-mg doses were 71.0% and 54.0%, 74.4% and 65.4%, and 81.5% and 75.0%, respectively. There was a significant correlation between dose and plasma concentrations of risperidone plus 9-hydroxyrisperidone, and the estimated plasma concentration associated with 50% D(2) occupancy (ED(50)) was 11.06 ng/ml. Prolactin levels were not correlated with drug levels or D(2) occupancy. All three doses of injectable risperidone showed peak D(2) occupancy ...Continue Reading

Citations

Jul 27, 2007·Psychopharmacology·Donald F SmithRaben Rosenberg
Apr 2, 2010·European Journal of Clinical Pharmacology·Yasmin NazirizadehChristoph Hiemke
Apr 20, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·David MamoDavid McDonnell
Jun 1, 2009·Journal of Addiction Medicine·Charles W MeredithAndrew J Saxon
Feb 7, 2007·Current Opinion in Psychiatry·Gary Remington
Feb 3, 2009·Neuropsychiatric Disease and Treatment·Michael K Rainer
Feb 17, 2010·CNS Drugs·Sheridan M HoyGillian M Keating
Jun 24, 2010·Drugs·Claudine M Chwieduk, Gillian M Keating
Jan 19, 2012·Drugs & Aging·José Luis López-SendónJusto García de Yébenes
May 28, 2010·The British Journal of Psychiatry. Supplement·David Taylor
Nov 26, 2011·Expert Review of Clinical Pharmacology·Maria J Arranz, Janet C Munro
Apr 2, 2013·Expert Opinion on Drug Safety·José López-SendónJusto G de Yébenes
Aug 1, 2009·Expert Opinion on Drug Discovery·Gianluca NucciItalo Poggesi
Oct 19, 2006·Expert Opinion on Drug Safety·Maria A Mena, Justo G de Yébenes
Apr 28, 2011·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Euitae KimJun Soo Kwon
Sep 4, 2007·Schizophrenia Research·C RabinS J Siegel
Oct 31, 2012·Acta Psychiatrica Scandinavica·E Ceskova
Mar 25, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Roberto ErroMichele Tinazzi
Jun 4, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Takashi TsuboiHiroyuki Uchida
May 15, 2015·Indian Journal of Psychological Medicine·Jisha M LuccaRajesh Raman
Aug 16, 2011·Pharmacology, Biochemistry, and Behavior·Gary RemingtonSridhar Natesan
Aug 28, 2016·Psychiatry Research·Vijay KumarBangalore N Gangadhar
Nov 3, 2016·Journal of Clinical Psychopharmacology·Marina ŠagudMilivoj Kramarić
Nov 12, 2016·The Psychiatric Clinics of North America·Jonathan M MeyerStephen M Stahl
May 22, 2010·Expert Opinion on Pharmacotherapy·Andrea FagioliniBenjamin I Goldstein
Mar 7, 2013·CNS Spectrums·Debbi A Morrissette, Stephen M Stahl
Oct 10, 2007·Harvard Review of Psychiatry·W Gordon Frankle
Dec 22, 2011·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Euitae KimJun Soo Kwon
Jul 13, 2017·Expert Review of Clinical Pharmacology·Georgios SchoretsanitisJose de Leon
Sep 17, 2008·Journal of Clinical Psychopharmacology·Gagan Deep MallA Adityanjee
Feb 19, 2008·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Christian DolderZachariah Deyo
Jan 1, 2009·International Journal of Psychiatry in Clinical Practice·Hiroo Yoda, Hakuei Yamashita

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.